Big Time College Sports is not the worst thing about American universities

Posted on February 24, 2019 by admin

Johnny-footballJanuary 10, 2015- By Steven E. Greer, MD

I was chuckling at an irrelevant essay in the NY Post complaining about how college football Continue reading →

Posted in - Opinion, - Policy, Congress | Leave a comment

Once again, daily aspirin is shown to be deadly rather than beneficial

Posted on February 15, 2019 by admin

September 16, 2018- by Steven E. Greer, MD

The Healthcare Channel has been pounding the table for many years pushing back against the drug Continue reading →

Posted in - NEJM, - Pharma, Cardiac surgery, Cardiology, Gastroenterology and liver, Geriatrics, Internal Medicine, Neurology, Neurosurgery, Oncology, Vascular Surgery | Leave a comment

Don Berwick, MD: State health insurance exchanges

Posted on February 11, 2019 by admin

April 4, 2012

Posted in CMS, Congress, Harvard | Leave a comment

Don Berwick, MD: Changing from fee-for-service to bundled payments in Medicare and Medicaid

Posted on February 11, 2019 by admin

April 4, 2012

Posted in CMS, Harvard | Leave a comment

Don Berwick, MD: National Coverage Decisions

Posted on February 11, 2019 by admin

December 1, 2013- National Coverage Decisions (NCDs) are used by CMS to set guidelines as to Continue reading →

Posted in CMS, Harvard | Leave a comment

Don Berwick, MD: The Institute for Healthcare Improvement

Posted on February 11, 2019 by admin

Posted in CMS, Harvard | Leave a comment

Industry conflicts arise at PCORI threatening any real comparative effectiveness research

Posted on February 10, 2019 by admin

February 7, 2014- By Steven E. Greer, MD

The Patient Centered Outcome Research Institute (PCORI) was created by the PPACA “ObamaCare” law in 2010. Continue reading →

Posted in - Medical Devices, - Opinion, - Pharma, CMS, Congress, Yale | Leave a comment

Essay: The Sad State of Affairs for American Medicine Primary Care

Posted on February 1, 2019 by admin

December 26, 2018- by Steven E. Greer, MD

I am so saddened by the state of our profession. I have been in different industries and unaware Continue reading →

Posted in - Opinion, - Policy, CMS, Congress, Primary care medicine | Leave a comment

Review: “The Bleeding Edge” documentary on unsafe medical devices

Posted on February 1, 2019 by admin

November 1, 2018- by Steven E. Greer, MD

The Netflix 2018 documentary “The Bleeding Edge” reviews modern cases of medical devices Continue reading →

Posted in - Medical Devices, - Reviews, books, devices, FDA | Leave a comment

Review of immunotherapy and targeted therapy

Posted on January 5, 2019 by admin

June 17, 2016- interviewed by Steven E. Greer, MD

We interviewed Siwen Hu-Lieskovan MD, PhD of UCLA, an expert with immunotherapies for melanoma, to go over the Continue reading →

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

The Year in Review: 2018

Posted on December 31, 2018 by admin

December 29, 2018- by Steven E. Greer, MD

The biggest stories this year related Continue reading →

Posted in - Biotech, - Generics, - Medical Devices, - Opinion, - Pharma, - Policy, - Reviews, books, devices, - The Weekly Summary | Leave a comment

Essay: The Silos of American Healthcare Stifle Communication Between Providers

Posted on December 19, 2018 by admin

December 19, 2018- by Steven E. Greer, MD

I have a clinical practice that treats chronic conditions, among other things. I recently ran across a Continue reading →

Posted in - Opinion, CMS, Congress | Leave a comment

Essay: Everything you say can and will be used against you

Posted on December 18, 2018 by admin

November 10, 2018- by Steven E. Greer, MD

I keep telling people that “smart home” devices, such as Amazon’s Alexa, record everything Continue reading →

Posted in - Opinion, - Policy, Congress | Leave a comment

Insurance companies are not paying for Repatha and Praluent

Posted on December 15, 2018 by admin

Update November 2, 2018- Amgen slashed the annual cost of this drug to $6,000. Continue reading →

Posted in - Biotech, - Pharma, - Policy, Cardiac surgery, Cardiology, Henry Ford, Primary care medicine | Leave a comment

Is polio making a comeback?

Posted on December 12, 2018 by admin

Update November 13, 2018- Parents of children who died from this “polio-like” illness are accusing the Continue reading →

Posted in CDC, Congress, Infectious disease, Internal Medicine, Neurology, Neurosurgery, NIH, Pediatrics, Primary care medicine, Rheumatology | Leave a comment

Ocrelizumab (Ocrevus) versus Placebo in Primary Progressive Multiple Sclerosis

Posted on December 1, 2018 by admin

January 31, 2017- Interviewed by Steven E. Greer, MD Continue reading →

Posted in - Biotech, - NEJM, - Pharma, Neurology, Univ Texas | Leave a comment

How pain pills almost killed my mother after elective knee surgery

Posted on November 30, 2018 by admin

OxycontinMay 21, 2014- By Steven E. Greer, MD

My mother is in her 70’s and in good health except for debilitating knee arthritis. After considerable Continue reading →

Posted in - Opinion, - Policy, CDC, Congress, FDA, Orthopedic surgery, Plastic surgery | Leave a comment

CDC data on increasing suicide rates

Posted on November 28, 2018 by admin

August 2, 2018- interviewed by Steven E. Greer, MD

We interviewed Alex E. Crosby, MD, MPH of the CDC, Branch Chief of Surveillance, Division Continue reading →

Posted in CDC, Emergency medicine, Neurology, Psychology Psychiatry, Rehab | Leave a comment

Essay: 25-years ago, I was reborn

Posted on November 26, 2018 by admin

November 6, 2018- by Steven E. Greer, MD

I had forgotten about this until I saw a reminder on my computer. Continue reading →

Posted in - Opinion, Trauma Surgery | Leave a comment

Fox and Friends accidentally produces what could be the best discussion of Medicare-for-All

Posted on November 15, 2018 by admin

November 15, 2018- by Steven E. Greer, MD

I have cut the cord and no longer get cable TV. However, the free content posted on apps lets me Continue reading →

Posted in - Opinion, - Policy, CMS, Congress | Leave a comment